Last reviewed · How we verify
Incidence of acute kidney injury
Incidence of acute kidney injury is a Biologic drug developed by Hospices Civils de Lyon. It is currently in Phase 2 development.
At a glance
| Generic name | Incidence of acute kidney injury |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients
- Study of the Incidence and Prognosis of Intrahospital Acute Kidney Injury
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- Incidence and Prognostic of Cardiac Surgery-Associated Acute Kidney Injury: A Spanish Multicenter Study (SCARS-AKI)
- Venous Congestion And Delirium After Cardiac Surgery
- Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting (PHASE2)
- Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery (NA)
- The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Incidence of acute kidney injury CI brief — competitive landscape report
- Incidence of acute kidney injury updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI
Frequently asked questions about Incidence of acute kidney injury
What is Incidence of acute kidney injury?
Incidence of acute kidney injury is a Biologic drug developed by Hospices Civils de Lyon.
Who makes Incidence of acute kidney injury?
Incidence of acute kidney injury is developed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).
What development phase is Incidence of acute kidney injury in?
Incidence of acute kidney injury is in Phase 2.